Novartis India

The Executive Committee of Novartis made their first visit to India, together!   Hosting our Novartis CEO Vas Narasimhan and the entire Executive Committee of Novartis (ECN) at the largest Novartis Corporate Center, in Hyderabad, has been nothing short of exhilarating. This visit stands as a testament to our commitment to India as we continue to strengthen by expanding our operations footprint in the country.   The sheer energy of our leaders and associates during this two day visit has been palpable. As India continues to play a pivotal role in our global success, we are proud of our talent whose determination and commitment drives us as we continue to reimagine medicine to improve and extend people’s lives.   #Novartis #VasInIndia #ReimaginingMedicine #IndiaStory

When it comes to heart health, knowledge is key. This #WorldHeartDay, we’re breaking down barriers and spreading awareness about better heart health through the #UnblockedMovement, in association with The Times Of India and their Beat Bad Cholesterol initiative. Join the movement to discover facts about heart health—because a healthier heart starts with what you know.   #IndiaUnblocked #BeatBadCholesterol #HeartHealth

We firmly believe that through shared knowledge and collaboration, we can transform patient care and revolutionize healthcare at a global scale.   Our Global Head of Corporate Centers & Business Solutions, Naveen Gullapalli, stood testament to this conviction during the panel discussion ‘Transforming Patient Care: How Global Capability Centers are Revolutionizing Healthcare and Life Sciences’, at the 5th Edition of the ET Edge Global Capability Centers.   As the GCC's foster change in the healthcare landscape around the world, here’s a capture from the thought-provoking panel discussion where Naveen brilliantly encapsulated how Novartis, guided by our purpose and values, is at the helm of healthcare innovation. Naveen discussed how fundamentally promoting a culture of entrepreneurship and supporting "intrapreneurship" within the organization, coupled with balancing the cost of innovation and speed, is a great formula for driving success.   We're truly proud to have been a part of this enlightening event. This exchange solidifies our dedication, and we're excited to keep pioneering the transformation and deliver better health outcomes, one breakthrough at a time.   #NovartisIndia #LifeSciences #HealthcareInnovation #GlobalCapabilityCenters #GCC

At Novartis, our long-standing commitment to patients living with chronic myeloid leukemia (#CML) spans more than two decades, marked by breakthroughs that have helped transform what was once a life-limiting condition into a chronic one for many. Yet, there's more ground to cover. Many patients with newly diagnosed CML still need more options that balance efficacy and tolerability. That’s why at Novartis, we’re committed to pioneering targeted treatments for CML, and ensuring every patient has access to these innovative medicines. Learn more here: https://lnkd.in/gEi9TEgR #WorldCMLDay #ReimaginingMedicine #WinForPatients

Chronic myeloid leukemia (CML) is a type of cancer that affects the blood and bone marrow, where blood cells are made. Recognizing the symptoms of CML is crucial for early detection. These can include fatigue, weight loss, fever, and an enlarged spleen causing discomfort on the left side of the abdomen. Taking proactive steps with your healthcare provider for regular check-ups and monitoring can be beneficial, leading to better disease management and improved quality of life (#QoL). Learn more about CML and its management here: https://lnkd.in/gEi9TEgR #CMLAwarenessMonth #ReimaginingMedicine #WinForPatients

We believe that innovation is key to transforming healthcare and improving patient lives. Artificial Intelligence (AI) is helping Novartis increase patient access, improve customer experience, drive automation, provide predictive analytics and detect potential misconduct. It also has the potential to be used to improve the speed and accuracy of diagnosis, treatment protocols, drug discovery, drug development, patient monitoring, and patient care, among other applications that will improve patients’ lives and optimize the healthcare ecosystem. With AI aiding our digital strategy and transformation, it is crucial to ensure that these advancements are guided by ethical and responsible practices. Our approach to AI is guided by key principles aligned with our Code of Ethics, ensuring that we operate with integrity and accountability. As we continue to explore what AI can achieve in medicine, we will ensure that the use of AI systems has a clear purpose that is respectful of human rights, and is accurate, truthful, not misleading, and appropriate for their intended context. #ReimaginingMedicine #ArtificialIntelligence #AI

The untold story of our Development hub, in all its vibrance, reflects not just the embodiment of Novartis' global strategy but also an inspiring lesson in harnessing local talent. Comprising an array of versatile teams from diverse cultural and professional backgrounds, the hub is supporting our groundbreaking projects and contributing to fulfilling our purpose of reimagining medicine. Read through to know more about this Indian engine to our global dream. #DrugDevelopment #ResearchAndDevelopment  #WeAreNovartis #ReimaginingMedicine #UntoldStories

We are thrilled and honoured to receive the corporate award from the Chief Minister of Telangana Shri Revanth Reddy, for Highest Percentage of Women participation at the recently concluded NMDC Hyderabad Marathon 2024. The NMDC Hyderabad Marathon is India’s 2nd largest and a signature event of Hyderabad. Participation from Novartis at this marathon has been consistently increasing, and this year we had over 600 associates participating in the marathon. This recognition is a testament to our commitment and the efforts of our Wellbeing Employee Resource Group, bringing together diverse individuals to create a social impact through corporate involvement. We are extremely proud of all the participants. Let's continue to prioritize health and wellness and inspire others to do the same. #HealthAndWellness #EmployeeResourceGroup #WeAreNovartis

A testament to our continued focus on advanced use of data in decision making, we recently concluded the 13th edition of the Annual Statistics Conference Sankhya 2024. The conference presented a unique platform to explore 'The Transformative Power of Statistics' focusing on comprehending how statistics facilitates medical innovation by underlining its critical contribution in risk assessment, communication and thereby driving informed decisions in the pharmaceutical industry. Dr. Arijit Nag, Hematology and BMT Consultant from TATA Medical Centre, Kolkata delivered the keynote address and shared his insights on “Harnessing the power of statistics in Cancer medicine”. Since its launch in 2011, Sankhya has witnessed significant growth in both participant engagement and number of entries. This year's edition expanded its reach both internally across varied locations and externally, attracting participants from other leading pharmaceutical organizations, including PhD students join in for this 3-day conference. With more than 400 participants and over 74 abstract submissions across lively discussions on topics such as Clinical Development plan, statistical methodologies, data science, interactions with regulatory authorities, real world evidence, metaprogramming, and Health technology assessment, the conference proved to be a massive success. With Sankhya, we aim to shed light on the myriad applications of statistics and its potential to provoke medical revolutions. We're already looking forward to the next edition, where we’ll explore, learn, and collaborate further to continue advancing healthcare with the power of statistics. #Sankhya2024 #StatisticsInMedicine #ReimaginingMedicine #WeAreNovartis

Disability Pride Month is celebrated every July, to recognize and honor the diversity, experiences, and contributions of differently abled people. The month-long observance aims to de-stigmatize disabilities, promote better understanding, and foster an environment of respect and inclusion. In recognition of Disability Pride Month, CapABLE, our Employee Resource Group (ERG), collaborated with Dialogue in the Dark, a social enterprise, to organize a sensory experiential learning event at our Novartis Corporate Center (NOCC) in Hyderabad. The event provided 100+ associates with a unique opportunity in which the participants were immersed in simulated environments, bringing to light the challenges and experiences of differently abled associates, enhancing their understanding and appreciation for the abilities of Persons with Disabilities (PwDs), and in fostering an inclusive society. It is conversations like these that remind us of the multitude of experiences that make up our world, and how each one contributes to the strength of our community. Together, we believe that everyone has a unique role to play. And Disability Pride Month reminds us of our mission to shape a more accessible and inclusive world – one where every individual, no matter their physical or mental abilities, has the freedom to contribute and succeed. This is what we continue striving for, today and every day. #DisabilityPrideMonth #Inclusion #Diversity #Empowerment #WeAreNovartis